✦ LIBER ✦

Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma

✍ Scribed by Jürgen C. Becker, Mads H. Andersen, Valeska Hofmeister-Müller, Marion Wobser, Lidia Frey, Christiane Sandig, Steffen Walter, Harpreet Singh-Jasuja, Eckhart Kämpgen, Andreas Opitz, Marc Zapatka, Eva-B. Bröcker, Per thor Straten, David Schrama, Selma Ugurel

Book ID: 118256467
Publisher: Springer-Verlag
Year: 2012
Tongue: English
Weight: 792 KB
Volume: 61
Category: Article
ISSN: 0340-7004
DOI: 10.1007/s00262-012-1266-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Monitoring tumor antigen specific T-cell

Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination

✍ Pedro Romero; Jean-Charles Cerottini; DanielE. Speiser 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 198 KB

Function but not phenotype of melanoma p

Function but not phenotype of melanoma peptide-specific CD8+ T cells correlate with survival in a multiepitope peptide vaccine trial (ECOG 1696)

✍ Carsten Schaefer; Lisa H. Butterfield; Sandra Lee; Grace G. Kim; Carmen Visus; A 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 French ⚖ 707 KB

Prolonged Survival of Dendritic Cell-Vac

Prolonged Survival of Dendritic Cell-Vaccinated Melanoma Patients Correlates With Tumor-Specific Delayed Type IV Hypersensitivity Response and Reduction of Tumor Growth Factor -Expressing T Cells

✍ Lopez, M. N.; Pereda, C.; Segal, G.; Munoz, L.; Aguilera, R.; Gonzalez, F. E.; E 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 261 KB

A phase II trial of vaccination with aut

A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients

✍ Lorenzo Pilla; Roberto Patuzzo; Licia Rivoltini; Michele Maio; Elisabetta Pennac 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 454 KB

A new dendritic cell vaccine generated w

A new dendritic cell vaccine generated with interleukin-3 and interferon-β induces CD8+T cell responses against NA17-A2 tumor peptide in melanoma patients

✍ Myrto Trakatelli; Michel Toungouz; Didier Blocklet; Ygierne Dodoo; Laurence Gord 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 306 KB

Development of an allogeneic whole-cell

Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma

✍ A.N. Alexander; M.K. Huelsmeyer; Ann Mitzey; R.R. Dubielzig; I.D. Kurzman; E.G. 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 312 KB